Intrinsic Value of S&P & Nasdaq Contact Us

Verve Therapeutics, Inc. VERV NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.00
+34.8%

Verve Therapeutics, Inc. (VERV) has 12 identified peers for comparison in the Healthcare sector. Peers include ADPT, BEAM, BPMC, CRBU, CRSP, EDIT and others.

VERV has a market capitalization of $994.04M, compared to an average peer market cap of $2.23B. VERV is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message